Insider Transactions in Q4 2020 at Y M Abs Therapeutics, Inc. (YMAB)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 28
2020
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
7,000
-100.0%
|
$357,000
$51.98 P/Share
|
|
Dec 28
2020
|
Thomas Gad CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+50.0%
|
$14,000
$2.0 P/Share
|
|
Dec 16
2020
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
7,000
-100.0%
|
$371,000
$53.01 P/Share
|
|
Dec 16
2020
|
Thomas Gad CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+50.0%
|
$14,000
$2.0 P/Share
|
|
Dec 14
2020
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
4,000
-0.64%
|
$208,000
$52.89 P/Share
|
|
Dec 11
2020
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
50,000
-100.0%
|
$2,550,000
$51.17 P/Share
|
|
Dec 11
2020
|
Thomas Gad CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+50.0%
|
$100,000
$2.0 P/Share
|
|
Dec 10
2020
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
50,000
-100.0%
|
$2,500,000
$50.75 P/Share
|
|
Dec 10
2020
|
Thomas Gad CHIEF BUSINESS OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+50.0%
|
$100,000
$2.0 P/Share
|
|
Dec 03
2020
|
Pedro Claus Juan Moller San Director and CEO |
SELL
Open market or private sale
|
Indirect |
9,266
-1.5%
|
$463,300
$50.98 P/Share
|
|
Dec 02
2020
|
Pedro Claus Juan Moller San Director and CEO |
SELL
Open market or private sale
|
Indirect |
40,734
-6.2%
|
$2,077,434
$51.27 P/Share
|
|
Dec 02
2020
|
Vignesh Rajah SVP & CHIEF MEDICAL OFFICER |
BUY
Open market or private purchase
|
Indirect |
233
+12.07%
|
$11,883
$51.03 P/Share
|
|
Dec 01
2020
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
4,000
-0.64%
|
$204,000
$51.42 P/Share
|
|
Nov 18
2020
|
David N Gill Director |
SELL
Open market or private sale
|
Direct |
2,000
-100.0%
|
$90,000
$45.77 P/Share
|
|
Nov 18
2020
|
David N Gill Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$22,000
$11.16 P/Share
|
|
Nov 17
2020
|
Vignesh Rajah SVP & CHIEF MEDICAL OFFICER |
BUY
Open market or private purchase
|
Indirect |
1,464
+50.0%
|
$65,880
$45.74 P/Share
|
|
Nov 16
2020
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
4,000
-0.63%
|
$184,000
$46.17 P/Share
|
|
Nov 03
2020
|
David N Gill Director |
SELL
Open market or private sale
|
Direct |
4,000
-100.0%
|
$180,000
$45.0 P/Share
|
|
Nov 03
2020
|
David N Gill Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$44,000
$11.16 P/Share
|
|
Nov 02
2020
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
4,000
-0.63%
|
$172,000
$43.69 P/Share
|
|
Oct 15
2020
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
4,000
-0.63%
|
$156,000
$39.15 P/Share
|
|
Oct 01
2020
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect |
4,000
-0.62%
|
$152,000
$38.88 P/Share
|